Moreover, evidence has demonstrated that BMP2 is upregulated in many cancers, and is related to the progression and growth of malignant tumors including non-small-cell lung cancer [21], osteosarcoma [22], gastric cancer [23], and nasopharyngeal carcinoma [24]. The gene discussed is BMP2; the disease is cancer.